ESR1 and breast cancer: Remarkably, the findings reported in this work also support the use of selective modulation of intracellular ERα levels as a target to identify new compounds that affect E2:ERα signaling in BC cell proliferation and serve as the basis for future evaluation of Tel repurposing in the treatment of primary and metastatic BC.